Anna Bianchi-Smiraglia

7PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersReaction engineering (excl. nuclear reactions)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 30, 2025
Inhibitors of De Novo Guanylate Biosynthesis Enhance the Potency of MAPK Cascade Inhibitors Against Colorectal Cancer.

Alexei A Maslov, Nicholas H Trageser, Julia V Kichina

|Oct 29, 2025
Inhibition of the RAC/PAK Signaling Axis Enhances the Potency of MAPK Cascade Inhibitors Against Uveal Melanoma.

Alexei A Maslov, Nicholas H Trageser, Julia V Kichina

|Oct 20, 2021
Regulation of local GTP availability controls RAC1 activity and cell invasion.

Anna Bianchi-Smiraglia, David W Wolff, Daniel J Marston

|Jan 09, 2020
Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy.

Hayley C Affronti, Aryn M Rowsam, Anthony J Pellerite

|Jan 22, 2019
KLF9-dependent ROS regulate melanoma progression in stage-specific manner.

Archis Bagati, Sudha Moparthy, Emily E Fink

|Feb 22, 2018
FOXQ1 controls the induced differentiation of melanocytic cells.

Archis Bagati, Anna Bianchi-Smiraglia, Sudha Moparthy

Pageof 2